By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cyclacel Pharmaceuticals, Inc. 

200 Connell Drive
Suite 1500
Berkeley Heights  New Jersey  07922  U.S.A.
Phone: 908-517-7330 Fax: 866-271-3466


SEARCH JOBS

Cyclacel Pharmaceuticals is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.

YEAR FOUNDED:

1996

LEADERSHIP:

Founder: Sir David Lane

CEO: Spiro Rombotis

JOBS:

Please click here for Cyclacel job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@cyclacel.com
Ownership: Public

Web Site: Cyclacel Pharma
Employees:
Symbol: CYCC
 









Company News
Cyclacel Pharma (CYCC) Reports Fourth Quarter And Full Year 2016 Financial Results 3/29/2017 9:26:39 AM
Cyclacel Pharma (CYCC) To Release Fourth Quarter And Full Year 2016 Financial Results 3/21/2017 9:05:08 AM
Cyclacel Pharma (CYCC)’s CDK Inhibitor CYC065 Causes Anaphase Catastrophe, A Novel Cancer-Specific Mechanism Of Action, In Research Published In JNCI 3/7/2017 8:31:13 AM
Cyclacel Pharma (CYCC) Crashes as Leukemia Drug Flunks Key Late-Stage Trial 2/23/2017 5:38:38 AM
Cyclacel Pharma (CYCC)’s Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential In Esophageal Cancer And Acute Leukemia 12/1/2016 7:12:53 AM
Cyclacel Pharma (CYCC) Reports 3rd Quarter 2016 Financial Results 11/15/2016 8:31:57 AM
Cyclacel Pharma (CYCC) To Release Third Quarter 2016 Financial Results 11/7/2016 7:48:59 AM
Cyclacel Pharma (CYCC)’s CYC065 Demonstrates Promising Activity In MYCN-Addicted Neuroblastoma In Preclinical Data Presented At Childhood Cancer 2016 9/6/2016 8:07:41 AM
The Reason Penny Stock Cyclacel Pharma (CYCC)'s Share Price Doubled the Past 10 Days 8/23/2016 6:18:47 AM
Cyclacel Pharma (CYCC) Reports 2nd Quarter 2016 Financial Results 8/11/2016 10:56:35 AM
12345678910...
//-->